Inograft Biotherapeutics

Inograft

Business Model
B2B
Last Round
Seed
Rounds
1

About

Preclinical-stage biotech developing novel non-immunogenic approaches for organ and tissue transplantation.

Summary

Inograft Biotherapeutics is a Biotech company based in Redwood City, United States. Investors include ARCH Venture Partners, Frazier Life Sciences and Sutter Hill.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed Round

Investors

Similar Companies